2026年10月13日 美国东部时间下午1:47 / 美国有线电视新闻网（CNN）
作者：卡拉·斯坎内尔
“药侠”马丁·什克雷利再次引起了联邦和州当局的注意。
因证券欺诈罪于2022年出狱的什克雷利，曾因将一款救命药的价格大幅抬高而臭名昭著。如今他一直在YouTube上直播自己的股票交易，其中涉及多家制药公司的多个持仓。
今年6月，他发起了一项交易竞赛，其交易账户声称拥有1000万美元资金，并此前吹嘘自己做空一家生物技术公司获得了成功。
美国联邦贸易委员会以及七个州的总检察长指控，什克雷利通过交易行为和社交媒体上的言论，“公然且屡次”违反了禁止他涉足制药行业的法院禁令。
周二，他们请求联邦法官裁定什克雷利藐视法庭，要求其退还交易所得的全部利润，并在他仍不停止的情况下将其送入监狱。
“除了公开的交易行为外，什克雷利本人也曾表示他还有其他账户，且大部分交易都不在社交媒体上进行，”当局在文件中写道。法庭文件显示，他们援引了什克雷利的原话：“我还有其他账户可以展示，但我知道联邦调查局在监视，所以算了吧，去他的。”
相关报道：马丁·什克雷利被勒令交出唯一一张武当派专辑的所有副本 阅读时长3分钟
2020年，联邦贸易委员会和包括纽约、加利福尼亚、伊利诺伊、北卡罗来纳、俄亥俄、宾夕法尼亚以及弗吉尼亚在内的七个州起诉什克雷利，指控其实施反竞争行为——他将治疗致命寄生虫病的救命药物达拉匹林（Daraprim）的价格一夜之间暴涨4000%，达到每片750美元。该案进入庭审程序，2022年1月，什克雷利被认定有罪，被勒令支付6460万美元罚款，并被禁止参与任何制药行业相关活动。
这起民事审判是在他另一桩刑事案件之后进行的：2018年，什克雷利因证券欺诈罪被判有罪，入狱七年，并于2022年5月获释。
联邦贸易委员会及各州指控，什克雷利几乎在获释后立刻就开始违反法院禁令：他发起了一项涉及至少11只制药股的交易竞赛，还开始做空生物技术公司卡瓦瓦科学公司（Cassava Sciences），押注该公司股价下跌。当局称，在直播中，什克雷利宣称该公司的临床试验注定会失败。
2024年11月21日，他在X平台上发文称：“我不是说它没用，而是它根本不可能起效。”
四天后，卡瓦瓦科学公司公开宣布其临床试验失败。
当局表示，什克雷利曾为自己的做空交易成功而“得意洋洋”。
“他们不想让你知道真相，他们想让你一直蒙在鼓里。我试着给你们一些建议，我有二十年的交易经验。我在这类二元事件中赚了很多钱，伙计们。有人说我在这方面是大佬，但你们根本不想听这些，”法庭文件援引什克雷利的话说道。
‘Pharma Bro’ Martin Shkreli has caught the attention of federal and state authorities again
2026-10-13 1:47 PM ET / CNN
By Kara Scannell
“Pharma Bro” Martin Shkreli has caught the attention of federal and state authorities again.
Since his 2022 release from prison for securities fraud, Shkreli — who gained national notoriety for inflating the price of a life-saving drug — has been livestreaming on YouTube his stock trades, including several positions involving pharmaceutical companies.
In June, he launched a trading competition with an account boasting a $10 million balance and earlier touted a successful short position he had taken on a biotech company.
The Federal Trade Commission and attorneys general from seven states alleged that through trading and statements on social media platforms, Shkreli has “flagrantly and repeatedly” violated the court order that barred him from participating in the pharmaceutical industry.
On Tuesday, they asked a federal judge to hold Shkreli in contempt, fine him the total profits he made from the trades, and potentially send him to prison if he doesn’t stop.
“In addition to his public trading, Shkreli himself has indicated that he has more accounts and does most of his trading off social media,” authorities wrote. They cited Shkreli saying, “I have some other accounts that I’[d] show you, but, like, I know feds are watching, so f*ck that,’” according to the court filing.
Related article: Martin Shkreli ordered to give up all copies of one-of-a-kind Wu-Tang Clan album 3 min read
The FTC and seven states — New York, California, Illinois, North Carolina, Ohio, Pennsylvania and Virginia — sued Shkreli in 2020 for anticompetitive behavior for raising the price of Daraprim, a life-saving drug for a toxic parasitic disease, by 4,000% overnight to $750 per pill. The case went to trial, and in January 2022, Shkreli was found liable, ordered to pay $64.6 million and banned from any activity in the pharmaceutical industry.
The civil trial followed his separate criminal case in which Shkreli was found guilty of securities fraud in 2018 and sentenced to seven years in prison. He was released in May 2022.
Almost immediately, the FTC and states allege, Shkreli began violating the court’s ban by setting up a trading competition involving at least 11 pharmaceutical stocks. He also started shorting, or betting the price of biotech company Cassava Sciences would drop. During his livestreams, authorities say, Shkreli argued the company’s clinical study was doomed to fail.
On November 21, 2024, on X, he said, “I don’t think it doesn’t work. It is impossible for it to work.”
Four days later, Cassava publicly said the clinical study failed.
Authorities say Shkreli “gloated” about the success of his short position.
“They don’t want you to know. They want you to stay stupid. I try to give you some advice. Twenty years of experience. I made a lot of money in these binary events, man. Some people say that I’m the GOAT at it, but you didn’t want to hear nothing,” Shkreli said, according to the court filing.
发表回复